Search research articles
Contact Us
Filters
Showing results (131-140 of 215) with videos related to
Page
of 22
Sort By:
Endocrine-Related Cancer
|
September 25, 2009
Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis
Cristina Rodríguez-Antona, Judith Pallares, Cristina Montero-Conde, et al.
Cancer Research
|
July 19, 2012
Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity
Luis J Leandro-García, Susanna Leskelä, Lucía Inglada-Pérez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations
Marianthi Georgitsi, Anniina Raitila, Auli Karhu, et al.
Nature Reviews. Endocrinology
|
November 19, 2016
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas
, Rodrigo A Toledo, Nelly Burnichon, et al.
International Journal of Cancer
|
January 3, 2014
DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival
Veronika Mancikova, Raquel Buj, Esmeralda Castelblanco, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 2, 2025
Long-term persistence of glycemic dysregulation in patients with a history of pheochromocytoma/paraganglioma
Alessa Fischer, Hanna Remde, Christina Pamporaki, et al.
International Journal of Cancer
|
April 10, 2015
Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations
Veronika Mancikova, Raquel Cruz, Lucía Inglada-Pérez, et al.
The Oncologist
|
November 25, 2018
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
Lara Sánchez-Barroso, Maria Apellaniz-Ruiz, Gerardo Gutiérrez-Gutiérrez, et al.
Orphanet Journal of Rare Diseases
|
January 26, 2024
Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome
Ana Beatriz Sánchez-Heras, Estela Dámaso, Adela Castillejo, et al.
JCI Insight
|
October 5, 2016
Deep sequencing reveals microRNAs predictive of antiangiogenic drug response
Jesús García-Donas, Benoit Beuselinck, Lucía Inglada-Pérez, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 215) with videos related to
Sort By:
Page
of 22
Endocrine-Related Cancer
|
September 25, 2009
Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis
Cristina Rodríguez-Antona, Judith Pallares, Cristina Montero-Conde, et al.
Cancer Research
|
July 19, 2012
Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity
Luis J Leandro-García, Susanna Leskelä, Lucía Inglada-Pérez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations
Marianthi Georgitsi, Anniina Raitila, Auli Karhu, et al.
Nature Reviews. Endocrinology
|
November 19, 2016
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas
, Rodrigo A Toledo, Nelly Burnichon, et al.
International Journal of Cancer
|
January 3, 2014
DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival
Veronika Mancikova, Raquel Buj, Esmeralda Castelblanco, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 2, 2025
Long-term persistence of glycemic dysregulation in patients with a history of pheochromocytoma/paraganglioma
Alessa Fischer, Hanna Remde, Christina Pamporaki, et al.
International Journal of Cancer
|
April 10, 2015
Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations
Veronika Mancikova, Raquel Cruz, Lucía Inglada-Pérez, et al.
The Oncologist
|
November 25, 2018
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
Lara Sánchez-Barroso, Maria Apellaniz-Ruiz, Gerardo Gutiérrez-Gutiérrez, et al.
Orphanet Journal of Rare Diseases
|
January 26, 2024
Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome
Ana Beatriz Sánchez-Heras, Estela Dámaso, Adela Castillejo, et al.
JCI Insight
|
October 5, 2016
Deep sequencing reveals microRNAs predictive of antiangiogenic drug response
Jesús García-Donas, Benoit Beuselinck, Lucía Inglada-Pérez, et al.
Page
of 22